Chenbei Li

433 total citations · 1 hit paper
23 papers, 265 citations indexed

About

Chenbei Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Chenbei Li has authored 23 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Chenbei Li's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Chenbei Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Chenbei Li collaborates with scholars based in China and United States. Chenbei Li's co-authors include Chao Tu, Zhihong Li, Chengyao Feng, Hua Wang, Shasha He, Zhaoqi Li, Zijian Xiong, Daxiong Xiang, Junyong Wu and Xinyan Hao and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Chenbei Li

20 papers receiving 264 citations

Hit Papers

Nanomaterials for bone metastasis 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenbei Li China 8 112 48 47 38 37 23 265
Yu Pang China 8 121 1.1× 81 1.7× 54 1.1× 73 1.9× 48 1.3× 24 359
Nan Ouyang China 12 202 1.8× 59 1.2× 72 1.5× 56 1.5× 15 0.4× 26 332
Deborah D. Chin United States 9 158 1.4× 76 1.6× 89 1.9× 34 0.9× 24 0.6× 12 376
Xiaopeng Guo China 11 82 0.7× 83 1.7× 55 1.2× 28 0.7× 45 1.2× 31 337
Hongqian Guo China 10 170 1.5× 45 0.9× 70 1.5× 11 0.3× 52 1.4× 28 331
Hongyu Zhang China 8 89 0.8× 26 0.5× 35 0.7× 23 0.6× 71 1.9× 24 260
Ching-Yun Hsu United States 10 126 1.1× 38 0.8× 42 0.9× 11 0.3× 27 0.7× 10 314
Chuanfei Li China 9 191 1.7× 43 0.9× 87 1.9× 16 0.4× 19 0.5× 20 287
Ao Yu United States 9 186 1.7× 94 2.0× 58 1.2× 29 0.8× 81 2.2× 16 368

Countries citing papers authored by Chenbei Li

Since Specialization
Citations

This map shows the geographic impact of Chenbei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenbei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenbei Li more than expected).

Fields of papers citing papers by Chenbei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenbei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenbei Li. The network helps show where Chenbei Li may publish in the future.

Co-authorship network of co-authors of Chenbei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chenbei Li. A scholar is included among the top collaborators of Chenbei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenbei Li. Chenbei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hua, Yu He, Lu Wan, et al.. (2025). Deep learning models in classifying primary bone tumors and bone infections based on radiographs. npj Precision Oncology. 9(1). 72–72. 11 indexed citations
3.
Liu, Binfeng, Chenbei Li, Shasha He, et al.. (2025). Ubiquitin-conjugating enzyme E2S (UBE2S) as a prognostic biomarker and regulator of tumorigenesis in osteosarcoma. International Immunopharmacology. 154. 114545–114545. 6 indexed citations
4.
Wang, Hua, Yunyun Liu, Chenbei Li, et al.. (2025). Heavy metals, epigenetic aging, and mortality: A cohort study. Ecotoxicology and Environmental Safety. 303. 118826–118826.
5.
Feng, Chengyao, Wenchao Zhang, Lin Qi, et al.. (2024). Mitigation of Cisplatin-Induced Nephrotoxicity and Augmentation of Anticancer Potency via Tea Polyphenol Nanoparticles’ Codelivery of siRNA from CRISPR/Cas9 Screened Targets. ACS Applied Materials & Interfaces. 16(44). 59721–59737. 5 indexed citations
6.
Xiong, Zijian, et al.. (2024). A review on the crosstalk between non-coding RNAs and the cGAS-STING signaling pathway. International Journal of Biological Macromolecules. 283(Pt 3). 137748–137748. 3 indexed citations
7.
Wang, Siyu, Hua Wang, Chenbei Li, et al.. (2024). Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications. SHILAP Revista de lepidopterología. 5(3). e489–e489. 6 indexed citations
8.
Xu, Ruiling, Chenbei Li, Hua Wang, et al.. (2024). Deep learning-based artificial intelligence for assisting diagnosis, assessment and treatment in soft tissue sarcomas. SHILAP Revista de lepidopterología. 2(2). 100069–100069. 2 indexed citations
9.
Wang, Hua, et al.. (2024). Liquid-liquid phase separation in aging: Novel insights in the pathogenesis and therapeutics. Ageing Research Reviews. 102. 102583–102583. 4 indexed citations
10.
Hao, Xinyan, Junyong Wu, Daxiong Xiang, et al.. (2024). Nanomaterials for bone metastasis. Journal of Controlled Release. 373. 640–651. 89 indexed citations breakdown →
11.
Tu, Chao, Binfeng Liu, Chenbei Li, et al.. (2023). Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma. SHILAP Revista de lepidopterología. 4(5). e369–e369. 4 indexed citations
13.
Liu, Binfeng, Chenbei Li, Chengyao Feng, et al.. (2023). Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma. Frontiers in Immunology. 14. 1178436–1178436. 2 indexed citations
14.
Li, Chenbei, Chengyao Feng, Ruiling Xu, et al.. (2023). The emerging applications and advancements of Raman spectroscopy in pediatric cancers. Frontiers in Oncology. 13. 1044177–1044177. 3 indexed citations
15.
Wang, Hua, Xiaowen Zhou, Chenbei Li, et al.. (2022). The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy. Journal of Hematology & Oncology. 15(1). 140–140. 49 indexed citations
16.
Liu, Zhongyue, Binfeng Liu, Chengyao Feng, et al.. (2022). Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma. Frontiers in Immunology. 13. 1071636–1071636. 11 indexed citations
17.
Liu, Binfeng, Chengyao Feng, Zhongyue Liu, et al.. (2022). Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma. Frontiers in Genetics. 13. 1063057–1063057. 9 indexed citations
18.
Li, Chenbei, et al.. (2022). A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021. Frontiers in Endocrinology. 13. 961471–961471. 11 indexed citations
19.
Wang, Siyu, Hua Wang, Chengyao Feng, et al.. (2022). The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases. Cell Death Discovery. 8(1). 492–492. 27 indexed citations
20.
Liu, Binfeng, Zhongyue Liu, Chengyao Feng, et al.. (2022). Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma. Frontiers in Endocrinology. 13. 987942–987942. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026